No Difference in 30-Day Outcome and Quality of Life in Transradial Versus Transfemoral Access - Results From the German Austrian ABSORB Registry (GABI-R).

Wein B, Zaczkiewicz M, Graf M, Zimmermann O, Gori T, Nef HM, Kastner J, Mehilli J, Richardt G, Wöhrle J, Achenbach S, Riemer T, Hamm C, Torzewski J (2022)

Publication Type: Journal article

Publication year: 2022

Journal

Cardiovascular Revascularization Medicine Elsevier

Book Volume: 40

Pages Range: 144-149

DOI: 10.1016/j.carrev.2021.11.022

Abstract

BACKGROUND: Radial (RA) instead of femoral access (FA) for coronary interventions has become a European Society of Cardiology Class-IA guideline recommendation. But when the decision on the access site is left to the discretion of the operator, differences in adverse event rates mitigate. METHODS: We compared the 30-day outcome for RA and FA in all patients recruited for the observational German Austrian ABSORB Registry (GABI-R) in regard to all-cause mortality, stroke, myocardial infarction (MI), TIMI major bleedings (TMB) and quality of life (QoL). All patients were treated with a bioresorbable vascular scaffold. Access site was left to the discretion of the operator. RESULTS: In total, 3137 patients included by 92 centers received percutaneous coronary interventions (PCI) for acute MI in 51.5% and non-acute settings in 48.5%. RA was performed in 47.8% and had a higher median radiation exposure (3896 vs. 3082 cGycm2, p < 0.001). There was no difference in the amount of contrast used. There was also no difference in all-cause mortality (0.53% vs. 0.49%, p = 0.86), the combination of death, MI and stroke (1.87% vs. 1.83%, p = 0.94), but a trend towards more TMB (0.47% vs. 1.04%, p = 0.07) with FA. These outcomes were consistent across the subgroups of patients with ST-elevation MI, non-ST-elevation-ACS and stable coronary artery disease. Finally, QoL did not differ between RA and FA. CONCLUSIONS: In this contemporary GABI-R cohort, in which access site was left to the discretion of the operator, both access routes were safe and equal concerning QoL (ClinicalTrials.gov; NCT02066623).

Authors with CRIS profile

Stephan Achenbach Lehrstuhl für Innere Medizin II

Involved external institutions

Segeberger Kliniken DE Germany (DE) Universitätsklinikum Augsburg DE Germany (DE) Krankenhaus Landshut-Achdorf (LAKUMED) DE Germany (DE) Universitätsklinikum Gießen und Marburg (UKGM) DE Germany (DE) IHF GmbH Institut für Herzinfarktforschung DE Germany (DE) Klinikverbund Kempten-Oberallgäu DE Germany (DE) Medizinische Universität Wien AT Austria (AT) Johannes Gutenberg-Universität Mainz (JGU) DE Germany (DE) Klinikum Friedrichshafen DE Germany (DE)

How to cite

APA:

Wein, B., Zaczkiewicz, M., Graf, M., Zimmermann, O., Gori, T., Nef, H.M.,... Torzewski, J. (2022). No Difference in 30-Day Outcome and Quality of Life in Transradial Versus Transfemoral Access - Results From the German Austrian ABSORB Registry (GABI-R). Cardiovascular Revascularization Medicine, 40, 144-149. https://dx.doi.org/10.1016/j.carrev.2021.11.022

MLA:

Wein, Bastian, et al. "No Difference in 30-Day Outcome and Quality of Life in Transradial Versus Transfemoral Access - Results From the German Austrian ABSORB Registry (GABI-R)." Cardiovascular Revascularization Medicine 40 (2022): 144-149.

BibTeX: Download